Increase
Decrease
Normal
Current Size:
100%
Search
Search
Home
About us
News
Contact us
General overview
Governance
Vacancies
Our staff
Links
Video gallery
Customer charter
Data & statistics
Data we collect
Data fields we collect
Performance indicators
Cancer factsheets
Incidence statistics
Survival statistics
Incidence rates mapped
Data request
Publications
Annual financial reports
Strategic plans
Cancer trends & projections
Statistical reports
Cancer atlases
Research publications
Research reports
Scientific papers
Presentations
All Ireland cancer statistics
Infographics
Research
Research projects
Research publications
Research reports
Scientific papers
Presentations
FAQs
All FAQs
FAQs about us
About our data & how we collect it
Using & interpreting our data
Cancer information
Troubleshooting
Home
About us
News
Contact us
General overview
Governance
Vacancies
Our staff
Links
Video gallery
Customer charter
Data & statistics
Data we collect
Data fields we collect
Performance indicators
Cancer factsheets
Incidence statistics
Survival statistics
Incidence rates mapped
Data request
Publications
Annual financial reports
Strategic plans
Cancer trends & projections
Statistical reports
Cancer atlases
Research publications
Research reports
Scientific papers
Presentations
All Ireland cancer statistics
Infographics
Research
Research projects
Research publications
Research reports
Scientific papers
Presentations
FAQs
All FAQs
FAQs about us
About our data & how we collect it
Using & interpreting our data
Cancer information
Troubleshooting
Data & statistics
Performance indicators
8B: Treatment - surgery
Data we collect
Data fields we collect
Performance indicators
Cancer factsheets
Incidence statistics
Survival statistics
Search all survival
Incidence rates mapped
Data request
Request specific grouped data
8B: Treatment - surgery
% of Cases treated with Surgery
UKIACR average (population)
UKIACR average (country)
England
Scotland
Wales
Northern Ireland
Republic of Ireland
All invasive xnmsc
46.7%
45.2%
47.7%
42.1%
38.7%
54.3%
43.1%
All xnmsc 0-24
48.5%
47.7%
49.2%
49.4%
47.3%
55.1%
37.4%
All xnmsc 25-59
63.6%
61.1%
64.9%
60.5%
54.7%
69.5%
56.0%
All xnmsc 60-79
46.5%
44.5%
47.7%
41.0%
39.0%
54.0%
40.6%
All xnmsc 80+
28.9%
27.8%
29.7%
23.5%
22.7%
35.3%
27.7%
Haematology
6.0%
8.4%
5.3%
3.8%
14.1%
9.2%
9.7%
Head and Neck
52.0%
49.6%
53.5%
44.2%
47.9%
53.6%
48.7%
Lower GI
65.5%
66.0%
66.0%
64.9%
56.8%
82.8%
59.5%
Upper GI
32.9%
27.6%
36.5%
15.4%
10.6%
49.0%
26.4%
HPB
29.3%
26.3%
31.7%
13.3%
10.8%
45.4%
30.0%
Trachea, Bronchus & Lung
22.2%
19.7%
23.8%
13.1%
16.1%
27.7%
17.9%
Melanoma
92.3%
90.9%
92.5%
98.1%
85.8%
89.6%
88.6%
Breast
75.9%
74.5%
76.7%
76.6%
70.7%
84.5%
64.2%
Cervix
58.6%
50.9%
64.2%
26.9%
44.0%
61.7%
57.4%
Other Female Genitals
72.3%
68.5%
73.8%
69.9%
57.6%
74.5%
66.9%
Prostate
21.5%
18.6%
22.3%
15.8%
14.3%
17.8%
22.9%
Kidney
59.3%
59.2%
59.9%
55.2%
48.8%
75.5%
56.8%
Bladder
81.6%
75.3%
84.0%
77.4%
77.3%
87.8%
50.0%
Brain and CNS
48.3%
51.7%
47.1%
55.1%
38.1%
58.4%
59.6%
Thyroid & other endocrine glands
79.1%
75.4%
80.6%
77.7%
65.6%
86.2%
67.1%
CUP
13.1%
11.7%
14.4%
6.8%
8.0%
19.6%
9.5%
Other invasive cancer
51.1%
49.1%
52.4%
45.4%
42.0%
56.8%
48.7%
Breast in situ
85.0%
84.4%
85.5%
94.2%
77.1%
95.8%
69.4%
Cervix in situ
82.3%
63.7%
87.9%
85.3%
58.5%
13.3%
73.4%
Other tumours
58.8%
54.4%
60.4%
60.9%
39.4%
47.6%
63.3%
Non-Melanoma Skin Cancer
50.7%
71.1%
43.1%
89.5%
85.3%
56.4%
80.9%
Printer-friendly version